Management of liver disease patients in different clinical situations during COVID-19 pandemic [0.03%]
COVID-19大流行期间不同临床情况下肝病患者的诊治
Samy Zaky,Mohamed Alboraie,Mohamed El Badry et al.
Samy Zaky et al.
Chronic liver diseases are common worldwide, especially in developing countries. The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/(COVID-19) leads to the infection of many patients with underlying chronic liv...
Identification and expression analysis of antigenic sites of hepatitis C virus genotype 3a NS3 and NS5A genes of local isolate [0.03%]
丙型肝炎病毒基因3a型NS3和NS5A基因抗原位点的鉴定及表达分析
Sabeen Sabri,Muhammad Idrees Khan,Shazia Rafique et al.
Sabeen Sabri et al.
Background: Hepatitis C virus, a silent killer, has infected 71 million people globally. The recombinant viral antigenic proteins might be used in the early diagnosis of HCV infection. The NS3 and NS5A genes of HCV functi...
Egyptian protocol for living donor liver transplantation (LDLT) during SARS-CoV-2 pandemic [0.03%]
COVID-19疫情期间的活体肝移植(Egyptian protocol for living donor liver transplantation LDLT)
Hany Said Abd Elbaset,Ahmad Mohammad Sultan,Iman Fawzy Montasser et al.
Hany Said Abd Elbaset et al.
Background: The current SARS-CoV-2 pandemic may negatively impact the care of liver transplant candidates and recipients. Main body of the abstract: ...
The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced [0.03%]
COVID-19患者肝损伤的风险和药物管理以降低或防止诱导的损伤
Antonio Vitiello,Raffaele La Porta,Vilma D&#x;Aiuto et al.
Antonio Vitiello et al.
Background: The global pandemic COVID-19 caused by the new coronavirus SARS-CoV-2 has already caused about 1.4 million deaths, and to date, there are no effective or direct antiviral vaccines. Some vaccines are in the las...
Growth differentiation factor 15: an emerging diagnostic biomarker of liver fibrosis in chronic hepatitis C patients [0.03%]
生长分化因子15：慢性丙型肝炎患者肝脏纤维化诊断的新兴生物标志物
Heba M Adel Abou Zaghla,Aziza Ahmed El Sebai,Ossama Ashraf Ahmed et al.
Heba M Adel Abou Zaghla et al.
Background: Chronic liver disease and cirrhosis are of the major health concern worldwide. Assessment of liver fibrosis is necessary to determine disease severity and prognosis at the time of presentation to determine sui...